Find policies, billing codes, payers, states, and providers
Loading...
Find policies, billing codes, payers, states, and providers
CPT 77750: Radioelement Instillation to Destroy Tumor Cells
CPT-77761-INTRACAVITARY-BRACHYTHERAPY-IMPLANTCPT 77761: Intracavitary Brachytherapy, 1–4 Sources
CPT-77762-BRACHYTHERAPY-INTRACAVITARY-INTERSTITIAL-IMPLANTCPT 77762: Intracavitary Brachytherapy with 5–10 Sources
CPT-77763-INTRACAVITARY-BRACHYTHERAPY-MULTI-SOURCE-IMPLANTATIONCPT 77763: Intracavitary Brachytherapy, >10 Radioactive Sources
CPT-77767-SURFACE-BRACHYTHERAPY-SKIN-TUMOR-SMALL-LESIONCPT 77767: High-Dose-Rate Brachytherapy for Skin Tumor ≤2.0 cm
CPT-77768-SURFACE-BRACHYTHERAPY-SKIN-TUMOR-LARGE-OR-MULTIPLE-LESIONSCPT 77768: Surface Brachytherapy for Skin Tumor >2.0 cm
CPT-77770-SINGLE-CHANNEL-BRACHYTHERAPY-CATHETER-PLACEMENTCPT 77770: Single-Channel Interstitial or Intracavitary Brachytherapy
CPT-77771-BRACHYTHERAPY-INTERSTITIAL-INTRACAVITARY-MULTI-CHANNELCPT 77771: Interstitial or Intracavitary Brachytherapy, 2–12 Channels
CPT-77772-HIGH-DOSE-RATE-MULTI-CHANNEL-BRACHYTHERAPYCPT 77772: Interstitial or Intracavitary Brachytherapy, >12 Channels
CPT-77778-INTERSTITIAL-BRACHYTHERAPY-MORE-THAN-10-SOURCESCPT 77778: Interstitial Brachytherapy, >10 Radioactive Sources
Showing 1–10 of 13
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.